224 related articles for article (PubMed ID: 23782868)
1. Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa.
Ikeda Y; Yoshida N; Notomi S; Murakami Y; Hisatomi T; Enaida H; Ishibashi T
Br J Ophthalmol; 2013 Sep; 97(9):1187-91. PubMed ID: 23782868
[TBL] [Abstract][Full Text] [Related]
2. The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa.
Ikeda Y; Hisatomi T; Yoshida N; Notomi S; Murakami Y; Enaida H; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2012 Jun; 250(6):809-14. PubMed ID: 22215259
[TBL] [Abstract][Full Text] [Related]
3. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
Grover S; Apushkin MA; Fishman GA
Am J Ophthalmol; 2006 May; 141(5):850-8. PubMed ID: 16546110
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa.
Liew G; Moore AT; Webster AR; Michaelides M
Invest Ophthalmol Vis Sci; 2015 Feb; 56(3):1531-6. PubMed ID: 25670491
[TBL] [Abstract][Full Text] [Related]
5. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM
Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176
[TBL] [Abstract][Full Text] [Related]
6. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Fishman GA; Apushkin MA
Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269
[TBL] [Abstract][Full Text] [Related]
7. RECURRENCE RATE OF CYSTOID MACULAR EDEMA WITH TOPICAL DORZOLAMIDE TREATMENT AND ITS RISK FACTORS IN RETINITIS PIGMENTOSA.
Shimokawa S; Murakami Y; Fujiwara K; Funatsu J; Nakatake S; Koyanagi Y; Akiyama M; Yoshida N; Takeda A; Ikeda Y; Sonoda KH
Retina; 2022 Jan; 42(1):168-173. PubMed ID: 34393209
[TBL] [Abstract][Full Text] [Related]
8. POSSIBLE EFFICACY OF TOPICAL DORZOLAMIDE IN THE TREATMENT OF PACLITAXEL-RELATED CYSTOID MACULAR EDEMA.
Dwivedi R; Tiroumal S
Retin Cases Brief Rep; 2018 Winter; 12(1):75-79. PubMed ID: 27749791
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa.
Grover S; Fishman GA; Fiscella RG; Adelman AE
Retina; 1997; 17(3):222-31. PubMed ID: 9196934
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
Genead MA; Fishman GA
Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa.
Chung H; Hwang JU; Kim JG; Yoon YH
Retina; 2006 Oct; 26(8):922-7. PubMed ID: 17031294
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa: A meta-analysis.
Huang Q; Chen R; Lin X; Xiang Z
PLoS One; 2017; 12(10):e0186180. PubMed ID: 29023491
[TBL] [Abstract][Full Text] [Related]
13. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa.
Giuffre G
Am J Ophthalmol; 2006 Oct; 142(4):707; author reply 707-8. PubMed ID: 17011883
[No Abstract] [Full Text] [Related]
14. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis.
Genead MA; Fishman GA; Walia S
Arch Ophthalmol; 2010 Feb; 128(2):190-7. PubMed ID: 20142541
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of topical dorzolamide therapy for cystoid macular edema in a patient with MFRP-related nanophthalmos-retinitis pigmentosa-foveoschisis-optic disk drusen syndrome.
Zacharias LC; Susanna R; Sundin O; Finzi S; Susanna BN; Takahashi WY
Retin Cases Brief Rep; 2015; 9(1):61-3. PubMed ID: 25383852
[TBL] [Abstract][Full Text] [Related]
16. Effect of Topical Dorzolamide on Cystoid Macular Edema in Retinitis Pigmentosa.
Shimokawa S; Fujiwara K; Murakami Y; Funatsu J; Nakatake S; Yoshida N; Sonoda KH; Ikeda Y
Ophthalmol Retina; 2020 Oct; 4(10):1036-1039. PubMed ID: 32454228
[No Abstract] [Full Text] [Related]
17. Correlations between spectral-domain OCT measurements and visual acuity in cystoid macular edema associated with retinitis pigmentosa.
Kim YJ; Joe SG; Lee DH; Lee JY; Kim JG; Yoon YH
Invest Ophthalmol Vis Sci; 2013 Feb; 54(2):1303-9. PubMed ID: 23329664
[TBL] [Abstract][Full Text] [Related]
18. Retrospective cohort study exploring whether an association exists between spatial distribution of cystoid spaces in cystoid macular oedema secondary to retinitis pigmentosa and response to treatment with carbonic anhydrase inhibitors.
Strong SA; Hirji N; Quartilho A; Kalitzeos A; Michaelides M
Br J Ophthalmol; 2019 Feb; 103(2):233-237. PubMed ID: 29706600
[TBL] [Abstract][Full Text] [Related]
19. DEXAMETHASONE IMPLANT VERSUS TOPICAL CARBONIC ANHYDRASE INHIBITORS IN PATIENTS WITH BILATERAL RETINITIS PIGMENTOSA-RELATED CYSTOID MACULAR EDEMA: A Prospective, Paired-Eye Pilot Study.
Colombo L; Montesano G; Di Domenico A; Colizzi B; Rissotto R; Maltese P; Bertelli M; Autelitano A; Rossetti L
Retina; 2024 May; 44(5):852-860. PubMed ID: 38166238
[TBL] [Abstract][Full Text] [Related]
20. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
Apushkin MA; Fishman GA; Grover S; Janowicz MJ
Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
